Pricing Log in Create free account

MaxCyte, Inc. (MXCT) vs RxSight, Inc. (RXST)

MaxCyte, Inc. and RxSight, Inc. are both Medical Devices companies. RxSight, Inc. is the larger, with a market value of $194.2M against $134.2M — 1.4× the size. MaxCyte, Inc. grew revenue faster over the last twelve months: −13.2% against −13.3%. RxSight, Inc. has the higher net margin (−36.8% vs −114.8%) and the lower return on invested capital (−63.2% vs −49.2%). Across the 17 metrics below, RxSight, Inc. leads on 11 and MaxCyte, Inc. on 6.

Valuation

Metric MXCT RXST Medical Devices median
P/E n/m n/m 23.22
P/S 4.47 1.47 2.34
P/B 0.87 0.71 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m 0.04 11.54
EV/Sales 1.23 (0.02) 2.24
Earnings yield (25.38%) (25.06%) (10.09%)
Free cash flow yield (17.02%) (14.52%) (8.47%)

Profitability

Metric MXCT RXST Medical Devices median
Gross margin 79.23% 77.50% 56.01%
Operating margin (134.59%) (43.20%) (15.03%)
Net margin (114.77%) (36.80%) (20.40%)
Free cash flow margin (76.14%) (21.29%) (7.24%)
Return on equity (20.39%) (17.35%) (15.32%)
Return on assets (17.62%) (14.19%) (19.72%)
Return on invested capital (49.23%) (63.16%) (10.33%)

Growth

Metric MXCT RXST Medical Devices median
Revenue growth (TTM) (13.15%) (13.25%) 8.80%
EPS growth (last fiscal year) (7.69%) (33.80%) 29.03%
Revenue growth, 5-year CAGR 4.76% 55.74% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MXCT RXST Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 12.26 4.07 2.50
Net debt to EBITDA 2.21 4.27 0.49

Dividend

Metric MXCT RXST Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric MXCT RXST Medical Devices median
Market cap 134.17m 194.24m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack